# Extracorporeal Blood Purification Therapy in Critically Ill Patients (GlobalARRT)

> **NCT04580680** · — · RECRUITING · sponsor: **Careggi Hospital** · enrollment: 1000 (estimated)

## Conditions studied

- Critical Illness
- Acute Kidney Injury
- Sepsis
- Systemic Inflammatory Response Syndrome

## Interventions

- **DEVICE:** Commercial membrane for Extracorporeal Blood Purification Therapy (EBPT)

## Key facts

- **NCT ID:** NCT04580680
- **Lead sponsor:** Careggi Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2020-11-01
- **Primary completion:** 2025-09-30
- **Final completion:** 2025-09-30
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2025-02-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04580680

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04580680, "Extracorporeal Blood Purification Therapy in Critically Ill Patients (GlobalARRT)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04580680. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*